Products progressing through the development pipeline to launch almost always require special resource allocations to overcome a unique blend of competitive pressures, clinical proficiency, commercial prospects, and regulatory hurdles. In order to meet sales expectations and achieve more explicit commercial objectives, drug companies must back their brand teams with the proper mix of budgets and staff from the appropriate support functions at the proper times. The commercialization of new drugs continues to challenge companies across the pharmaceutical and biotechnology sectors.

Enter Companies List ++